Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Significance of The Detection of Serum Lactate Dehydrogenase, Hypersensitive C-Reactive Protein, and N-Terminal Pro-Brain Natriuretic Peptide for the Evaluation of the Severity and Progression of Pediatric Patients with Traumatic Brain Injury

Author(s): Yu Liu, Peng Yang, Hao-Cheng Liu, Si Sun, Jia-Liang Zhang and Jun Kang*

Volume 19, Issue 2, 2022

Published on: 22 July, 2022

Page: [219 - 224] Pages: 6

DOI: 10.2174/1567202619666220713110941

Price: $65

conference banner
Abstract

Objective: This study aimed to investigate changes in the levels of serum lactate dehydrogenase (LDH), hypersensitive C-reactive protein (hs-CRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in pediatric patients with traumatic brain injury and the clinical significance of detecting these changes for the evaluation of injury severity and patient progress.

Methods: A retrospective study was conducted on 40 pediatric patients admitted to the Tongren Hospital of China Capital Medical University with traumatic brain injury between January 2018 and December 2019. Immunoturbidimetric assay and electrochemiluminescence were used to detect the serum levels of LDH, hs-CRP, and NT-proBNP. Correlation analysis was used to determine the degree of association between the indicators and the sensitivity and specificity of each indicator.

Results: The serum levels of LDH, hs-CRP, and NT-proBNP in the poor-prognosis group were higher than those in the good-prognosis group, and the differences were statistically significant (P < 0.05).

Conclusion: The detection of serum LDH, hs-CRP, and NT-proBNP might be of great significance for the evaluation of the severity of a traumatic brain injury, disease progression, and the prognosis of pediatric patients with traumatic brain injury. The combined detection of the relevant indicators could provide more effective sensitivity and specificity and therefore offer better guidance and assistance in clinical practice.

Keywords: Traumatic brain injury, serum lactate dehydrogenase (LDH), N-terminal pro-brain natriuretic peptide (NTproBNP), hypersensitive C-reactive protein (hs-CRP), prognosis.

« Previous Next »
[1]
Plesnila N. The immune system in traumatic brain injury. Curr Opin Pharmacol 2016; 26: 110-7.
[http://dx.doi.org/10.1016/j.coph.2015.10.008] [PMID: 26613129]
[2]
Mercier E, Boutin A, Lauzier F, et al. Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: Systematic review and meta-analysis. BMJ 2013; 346: f1757.
[http://dx.doi.org/10.1136/bmj.f1757]
[3]
Gyoneva S, Ransohoff RM. Inflammatory reaction after traumatic brain injury: Therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol Sci 2015; 36(7): 471-80.
[http://dx.doi.org/10.1016/j.tips.2015.04.003] [PMID: 25979813]
[4]
Szkandera J, Stotz M, Absenger G, et al. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer 2014; 110(1): 183-8.
[http://dx.doi.org/10.1038/bjc.2013.701] [PMID: 24201751]
[5]
Lee DG, Lee KS, Shim JJ, Yoon SM, Bae HG. Prognostic value of the c-reactive protein levels in the head injury. J Kor Neurotrauatol Soc 2005; 1(1): 57-60.
[http://dx.doi.org/10.13004/jknts.2005.1.1.57]
[6]
Saito Y, Nakao K, Itoh H, et al. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun 1989; 158(2): 360-8.
[http://dx.doi.org/10.1016/S0006-291X(89)80056-7] [PMID: 2521788]
[7]
Takahashi T, Allen PD, Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene. Circ Res 1992; 71(1): 9-17.
[http://dx.doi.org/10.1161/01.RES.71.1.9] [PMID: 1535030]
[8]
Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87(4): 1402-12.
[http://dx.doi.org/10.1172/JCI115146] [PMID: 1849149]
[9]
Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M. Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008; 21(7): 733-41.
[http://dx.doi.org/10.1038/ajh.2008.174] [PMID: 18464748]
[10]
Ramazani J, Hosseini M. Prediction of ICU mortality in critically ill children: Comparison of SOFA, GCS, and FOUR score. Med Klin Intensivmed Notf Med 2019; 114(8): 717-23.
[http://dx.doi.org/10.1007/s00063-018-0484-0] [PMID: 30276565]
[11]
Bullock RM, Chesnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2000; 17: 451-553.
[PMID: 17511557]
[12]
Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the lactate dehydrogenase assay. Cold Spring Harb Protoc 2018; 2018(6): 95497.
[http://dx.doi.org/10.1101/pdb.prot095497] [PMID: 29858337]
[13]
Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ. The regulation and function of lactate dehydrogenase A: Therapeutic potential in brain tumor. Brain Pathol 2016; 26(1): 3-17.
[http://dx.doi.org/10.1111/bpa.12299] [PMID: 26269128]
[14]
Livesey A, Garty F, Shipman AR, Shipman KE. Lactate dehydrogenase in dermatology practice. Clin Exp Dermatol 2020; 45(5): 539-43.
[http://dx.doi.org/10.1111/ced.14134] [PMID: 31755143]
[15]
Ding J, Karp JE, Emadi A. Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomark 2017; 19(4): 353-63.
[http://dx.doi.org/10.3233/CBM-160336] [PMID: 28582845]
[16]
Koziel D, Gluszek S, Matykiewicz J, Lewitowicz P, Drozdzak Z. Comparative analysis of selected scales to assess prognosis in acute pancreatitis. Can J Gastroenterol Hepatol 2015; 29(6): 299-303.
[http://dx.doi.org/10.1155/2015/392643] [PMID: 25996611]
[17]
Merkenschlager A, Sperl W, Bernhard M, et al. Pyruvate denhydrogenase deficiehcy presenting as Guillain - Barré syndrome. Neuropediatrics 2011; 42(S1): 6-19.
[18]
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018; 9: 754.
[http://dx.doi.org/10.3389/fimmu.2018.00754] [PMID: 29706967]
[19]
Su BJ, Dong Y, Tan CC, et al. Elevated Hs-CRP levels are associated with higher risk of intracranial arterial stenosis. Neurotox Res 2020; 37(2): 425-32.
[http://dx.doi.org/10.1007/s12640-019-00108-9] [PMID: 31691187]
[20]
Xu W, Ge Z, Cao J, Mao S, Ma K, Xia Z. Significance of the ratio of C-reactive protein to prealbumin in patients with traumatic brain injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2020; 32(8): 965-9.
[http://dx.doi.org/10.3760/cma.j.cn121430-20200428-00347] [PMID: 32912411]
[21]
Ondruschka B, Schuch S, Pohlers D, Franke H, Dreßler J. Acute phase response after fatal traumatic brain injury. Int J Legal Med 2018; 132(2): 531-9.
[http://dx.doi.org/10.1007/s00414-017-1768-2] [PMID: 29306988]
[22]
Di Castelnuovo A, Veronesi G, Costanzo S, et al. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the risk of stroke. Stroke 2019; 50(3): 610-7.
[http://dx.doi.org/10.1161/STROKEAHA.118.023218] [PMID: 30786848]
[23]
Rodriguez-Gonzalez M, Benavente-Fernandez I, Castellano-Martinez A, Lechuga-Sancho AM, Lubian-Lopez SP. NT-proBNP plasma levels as biomarkers for pulmonary hypertension in healthy infants with respiratory syncytial virus infection. Biomarkers Med 2019; 13(8): 605-18.
[http://dx.doi.org/10.2217/bmm-2018-0348] [PMID: 31157543]

Rights & Permissions Print Cite
Article Metrics
8
© 2024 Bentham Science Publishers | Privacy Policy